AU8968798A - Use of polycyclic steroid compounds for the manufacture of medicament for the treatment of cystic kidney diseases, vascular infarction, uremia and related conditions - Google Patents

Use of polycyclic steroid compounds for the manufacture of medicament for the treatment of cystic kidney diseases, vascular infarction, uremia and related conditions

Info

Publication number
AU8968798A
AU8968798A AU89687/98A AU8968798A AU8968798A AU 8968798 A AU8968798 A AU 8968798A AU 89687/98 A AU89687/98 A AU 89687/98A AU 8968798 A AU8968798 A AU 8968798A AU 8968798 A AU8968798 A AU 8968798A
Authority
AU
Australia
Prior art keywords
uremia
medicament
manufacture
treatment
related conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU89687/98A
Inventor
Philip D. Acott
John F. S. Crocker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalhousie University
Original Assignee
Dalhousie University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalhousie University filed Critical Dalhousie University
Publication of AU8968798A publication Critical patent/AU8968798A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU89687/98A 1997-08-29 1998-08-28 Use of polycyclic steroid compounds for the manufacture of medicament for the treatment of cystic kidney diseases, vascular infarction, uremia and related conditions Abandoned AU8968798A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5726797P 1997-08-29 1997-08-29
US60057267 1997-08-29
PCT/CA1998/000825 WO1999011271A1 (en) 1997-08-29 1998-08-28 Use of polycyclic steroid compounds for the manufacture of a medicament for the treatment of cystic kidney diseases, vascular infarction, uremia and related conditions

Publications (1)

Publication Number Publication Date
AU8968798A true AU8968798A (en) 1999-03-22

Family

ID=22009550

Family Applications (1)

Application Number Title Priority Date Filing Date
AU89687/98A Abandoned AU8968798A (en) 1997-08-29 1998-08-28 Use of polycyclic steroid compounds for the manufacture of medicament for the treatment of cystic kidney diseases, vascular infarction, uremia and related conditions

Country Status (3)

Country Link
AU (1) AU8968798A (en)
CA (1) CA2302243A1 (en)
WO (1) WO1999011271A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2378898A (en) 2001-08-14 2003-02-26 Hunter Fleming Ltd Prophylactic and therapeutic use of hydroxysteroids
GB0601092D0 (en) * 2006-01-19 2006-03-01 Daniolabs Ltd The Prevention Of Systemic Side-Effects Of Glucocorticoids

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175144A (en) * 1988-11-29 1992-12-29 The Johns Hopkins University Method of retarding the progression of chronic renal failure

Also Published As

Publication number Publication date
WO1999011271A1 (en) 1999-03-11
CA2302243A1 (en) 1999-03-11

Similar Documents

Publication Publication Date Title
AU3673499A (en) Hydrogel for the therapeutic treatment of aneurysms
AUPP609198A0 (en) Use of non-peptidyl compounds for the treatment of insulin related ailments
AU2639695A (en) Novel uses of triplex forming oligonucleotides for the treatment of human diseases
HUP9700603A3 (en) Pharmaceutical preparation for the treatment of blood coagulation disorders
AU3548795A (en) Benzopyranopyrazolyl derivatives for the treatment of inflammation
AU5981098A (en) Therapeutic gestagens for the treatment of premenstrual dysphoric disorder
AU3891299A (en) Combination therapy for treatment of depression
AU2388895A (en) Substituted cyclopentadienyl compounds for the treatment of inflammation
AU2508597A (en) Drug for the treatment of tumours
AU7622000A (en) Compounds for the treatment of viral-mediated diseases
EP0765663A3 (en) Use of dienogest for the manufacture of a medicament for the treatment of the skin by topical application
AU2424895A (en) Substituted spirodienes for the treatment of inflammation
AU4774597A (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
AU3046897A (en) Uridine-comprising therapeutic active agent for treatment of neurodegenerative disorders
AU5056099A (en) Compounds for use in the treatment of inflammation
AU7484596A (en) Combination therapy for the treatment of diabetes and obesity
AU7106300A (en) Treatment of skin disorders
AU2265695A (en) The use of sertraline to treat cancer patients
AU4215499A (en) Treatment of neurodegenerative diseases
AU8968798A (en) Use of polycyclic steroid compounds for the manufacture of medicament for the treatment of cystic kidney diseases, vascular infarction, uremia and related conditions
AU3899100A (en) Treatment of hyperactivity disorders
AU1940800A (en) Combination therapy for the treatment of sepsis
AU2566201A (en) Compounds and methods for the treatment of pain
AU7726796A (en) Use of 3-oxa-d-prostaglandins for the manufacture of a medicament for the treatment of glaucoma
AU2462097A (en) The use of a substance p antagonist for the manufacture of medicament for the treatment of ocular pain

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase